Olga Wesolowska

Wroclaw Medical University

Poland

Research Interests

Explore related searches

Professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (8)

Krystyna Michalak

Professor

Wroclaw Medical University

POLAND

View details

Mateusz Chmielarz

Pomeranian Medical University

POLAND

View details

Kamila Środa-Pomianek

Wroclaw Medical University

POLAND

View details

Agata Kozioł

Medical University of Silesia

POLAND

View details

Anna Palko-Labuz

Wroclaw Medical University

POLAND

View details

Beata Sobieszczanska

professor

Medical University

POLAND

View details

Mirosława Ferens-Sieczkowska

assistant professor, associate professor

Medical University of Silesia

POLAND

View details

Magdalena Skonieczna

Silesian University of Technology

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Olga Wesolowska

Research Interests

Explore related searches

Contact this professor

Articles (10)

Correction: Maksymowicz et al. The Use of Endo-Cellulase and Endo-Xylanase for the Extraction of Apple Pectins as Factors Modifying Their Anticancer Properties and Affecting Their Synergy with the Active Form of Irinotecan. Pharmaceuticals 2022, 15, 732

Acridine-Based Chalcone 1C and ABC Transporters

New Hydrazone Derivatives Based on Pyrazolopyridothiazine Core as Cytotoxic Agents to Colon Cancers: Design, Synthesis, Biological Evaluation, and Molecular Modeling

Pretreatment of Melanoma Cells with Aqueous Ethanol Extract from Madhuca longifolia Bark Strongly Potentiates the Activity of a Low Dose of Dacarbazine

The Use of Endo-Cellulase and Endo-Xylanase for the Extraction of Apple Pectins as Factors Modifying Their Anticancer Properties and Affecting Their Synergy with the Active Form of Irinotecan

Newly Obtained Apple Pectin as an Adjunct to Irinotecan Therapy of Colorectal Cancer Reducing <i>E. coli</i> Adherence and β-Glucuronidase Activity

Conjugation with phospholipids as a modification increasing anticancer activity of phenolic acids in metastatic melanoma - in vitro and in silico studies

Isobavachalcone as an active membrane perturbing agent and inhibitor of ABCB1 multidrug transporter

TMPE derived from saffron natural monoterpene as cytotoxic and multidrug resistance reversing agentin colon cancer cells

Organosilicon Compounds, SILA-409 and SILA-421, as Doxorubicin Resistance-Reversing Agents in Human Colon Cancer Cells

Collaborators (8)

Krystyna Michalak

Mateusz Chmielarz

Kamila Środa-Pomianek

Agata Kozioł

Anna Palko-Labuz

Beata Sobieszczanska

Mirosława Ferens-Sieczkowska

Magdalena Skonieczna

Make your next move.